Hypertension, Vol 22, 618-629, Copyright © 1993 by American Heart Association
T Doetschman, M Shull, A Kier and JD Coffin
To better understand the formation of the cardiovascular system and its
disease states, models amenable to manipulation must be developed. In this
article we present two models. One is a small animal model for an
inflammatory disorder that can lead to heart failure. Production of this
model is based on the ability of blastocyst-derived embryonic stem cells,
which can be genetically altered in vitro by a technique called gene
targeting, to reconstitute an entire animal when reintroduced into a
blastocyst and allowed to colonize the germ line of the resulting chimeric
embryo. The other model is based on the capacity of embryonic stem cells to
differentiate in culture into embryo-like structures called embryoid
bodies. Embryoid bodies contain angioblasts, or prevascular endothelial
cells, which can be induced to undergo aspects of vascular development by
manipulation of culture conditions.
ARTICLES
Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders
Department of Molecular Genetics, University of Cincinnati College of Medicine, Ohio 45267-0524.
This article has been cited by other articles:
![]() |
Z. Li, J. C. Wu, A. Y. Sheikh, D. Kraft, F. Cao, X. Xie, M. Patel, S. S. Gambhir, R. C. Robbins, J. P. Cooke, et al. Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease Circulation, September 11, 2007; 116(11_suppl): I-46 - I-54. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parisi, D. D'Andrea, C. T. Lago, E. D. Adamson, M. G. Persico, and G. Minchiotti Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells J. Cell Biol., October 27, 2003; 163(2): 303 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Goldenthal and J. Marin-Garcia Stem cells and cardiac disorders: an appraisal Cardiovasc Res, May 1, 2003; 58(2): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, J.-Y. Min, J. S. Rana, Q. Ke, J. Cai, Y. Chen, J. P. Morgan, and Y.-F. Xiao VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells J Appl Physiol, September 1, 2002; 93(3): 1140 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Reinlib and L. Field Cell Transplantation as Future Therapy for Cardiovascular Disease? : A Workshop of the National Heart, Lung, and Blood Institute Circulation, May 9, 2000; 101 (18): e182 - e187. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mueller-Klieser Three-dimensional cell cultures: from molecular mechanisms to clinical applications Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1109 - C1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vittet, T. Buchou, A. Schweitzer, E. Dejana, and P. Huber Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies PNAS, June 10, 1997; 94(12): 6273 - 6278. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Weiler-Guettler, W. Aird, H Rayburn, M Husain, and R. Rosenberg Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos Development, July 1, 1996; 122(7): 2271 - 2281. [Abstract] [PDF] |
||||
![]() |
T. Schlaeger, Y Qin, Y Fujiwara, J Magram, and T. Sato Vascular endothelial cell lineage-specific promoter in transgenic mice Development, January 4, 1995; 121(4): 1089 - 1098. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |